Medline ® Abstract for Reference 52
of 'Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease'
PARP inhibitors for targeted treatment in ovarian cancer.
Women's Cancers, Lifespan Cancer Institute, Medical Oncology, Rhode Island Hospital, Medicine, Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: don.dizon@Lifespan.org.